Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Physiomics Share News (PYC)
PYC Share
Price
PYC Share
News
PYC Share
Chat
PYC Share
Trades9
PYC
Live RNS
PYC Share
Charts
PYC Level 2
Console
PYC Live
Share Price
PYC Broker
Ratings
PYC Directors
Deals
PYC Financial
Diary
PYC
Fundamentals
PYC Short
Positions
PYC
Media
PYC Company
Research
PYC Company
Timeline
Share Price Information for Physiomics (PYC)
Last checked at -
Last checked at 
Intraday Physiomics Share Chart
LONDON (Alliance News) - Physiomics PLC Monday said it has signed a contract with a new speciality pharmaceuticals customer to investigate how one of the client's new candidate drugs shrinks tumours.
Physiomics scientists will use systems biology approaches to map the possible pathways by which the drug could act, it said in a statement without giving any financial details. The analysis will be used to narrow down possible mechanisms and suggest new experiments that the client can perform to home in on one mechanism.
"If successful, the directors hope that Physiomics will be able to offer its other modelling services to this new client as the project progresses," the company said in a statement.
Physiomics shares were up 31.6% at 0.25 pence early Monday, the biggest gainer on AIM.
By Steve McGrath; stevemcgrath@alliancenews.com; @SteveMcGrath1
Copyright 2013 Alliance News Limited. All Rights Reserved.
Latest PYC News
- Small caps round-up: K3, Densitron, Innovation...
1 Mar 2012 - London close: Good gains as FTSE 100 rallies
13 Sep 2011 - London midday: Eurozone worries resurface
13 Sep 2011 - Physiomics wins prostate cancer drug deal
13 Sep 2011 - London midday: FTSE 100 stable after calm start
15 Aug 2011 - Cancer results boost Sareum
15 Aug 2011 - Physiomics issues shares at discount
6 Apr 2011 - Physiomics hits 52-week high on study outcome
1 Apr 2011
Related News
Physiomics reports strong operational progress
(Sharecast News) - Physiomics said on Friday that it was making strong operational progress and building the largest commercial pipeline in its histor...
Physiomics reports strong operational progress
(Sharecast News) - Physiomics said on Friday that it was making strong operational progress and building the largest commercial pipeline in its histor...
Physiomics hails progress despite one-off costs to replace board
(Alliance News) - Physiomics PLC on Friday said it "continues to make strong operational progress" but noted one-off costs from the dismissal of its p...
Physiomics News
Small caps round-up: K3, Densitron, Innovation...
Software firm K3 Business Technology Group has received a number of indicative proposals at levels materially higher than the current share price, whi...
London close: Good gains as FTSE 100 rallies
Stocks rediscovered their earlier buoyancy to finish with strong gains as hopes of a resolution of the euro crisis attracted buyers. Today's big move...
London midday: Eurozone worries resurface
This morning's bright start seems a distant memory now, with shares firmly in the red as worries over the Eurozone situation take centre stage again. ...
Physiomics wins prostate cancer drug deal
Physiomics, which makes computer models that simulate biological cell behaviour, has agreed to collaborate over development of a prostate cancer drug....
London midday: FTSE 100 stable after calm start
Shares are holding onto their gains today amid much calmer trading than the volatility seen last week. In company news, international recruitment fir...
Cancer results boost Sareum
Cancer drug discovery business Sareum shot ahead after it said it had selected a "preclinical development candidate" from research into Chk1, a method...
Physiomics issues shares at discount
Penny stock Physiomics fell sharply Wednesday, giving back some of last week's heavy gains, after announcing a share issue at a discount to the prevai...
Physiomics hits 52-week high on study outcome
The Oxford based systems biology company Physiomics said positive results have been generated in a pre-clinical study into breast cancer based on the ...
Follow the stocks
